secwatch.observer — SEC 8-K summary
======================================

Issuer:     Doximity, Inc. (DOCS)
CIK:        0001516513
Form:       8-K
Filed at:   2025-02-06T23:59:59+00:00
Accession:  0001516513-25-000009
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Doximity Q3 revenue up 25% YoY to $168.6M; adjusted EBITDA up 39%
-----------------------------------------------------------------

- GAAP net income $75.2M ($0.37 diluted EPS) vs $48.0M YoY; non-GAAP net income $91.4M ($0.45) vs $58.5M.
- Revenue $168.6M (+25% YoY); adjusted EBITDA $102.0M, margin 60.5%.
- Record engagement: 610,000+ unique providers using clinical workflow tools; AI tools up 60% QoQ.
- Q4 guidance: revenue $132.5–$133.5M; adjusted EBITDA $62.5–$63.5M; FY2025 revenue guidance raised to $564.6–$565.6M.
- Operating cash flow $65.2M (+30% YoY); free cash flow $63.4M (+30% YoY).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516513/000151651325000009/0001516513-25-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516513/000151651325000009/docs-20250206.htm
  HTML page:      https://secwatch.observer/filing/0001516513-25-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer